These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7703491)

  • 1. Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome--associated non-Hodgkin's lymphoma.
    Yawetz S; Cumberland WG; van der Meyden M; Martínez-Maza O
    Blood; 1995 Apr; 85(7):1843-9. PubMed ID: 7703491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
    Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
    Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue.
    Schroeder JR; Saah AJ; Ambinder RF; Martinez-Maza O; Crabb Breen E; Variakojis D; Margolick JB; Jacobson LP; Rowe DT; Hoover DR
    Clin Immunol; 1999 Dec; 93(3):239-44. PubMed ID: 10600334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain.
    Bossolasco S; Nilsson A; de Milito A; Lazzarin A; Linde A; Cinque P; Chiodi F
    AIDS; 2001 Jun; 15(9):1109-13. PubMed ID: 11416712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum level of soluble CD23 precedes development of B-non-Hodgkin's lymphoma in SIV-infected Rhesus monkeys.
    Hannig H; Buske C; Mätz-Rensing K; Hunsmann G; Hiddemann W; Bodemer W
    Int J Cancer; 1998 Aug; 77(5):734-40. PubMed ID: 9688307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6.
    Breen EC; van der Meijden M; Cumberland W; Kishimoto T; Detels R; Martínez-Maza O
    Clin Immunol; 1999 Sep; 92(3):293-9. PubMed ID: 10479534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum measurements of soluble CD23 in HIV infection.
    Bansal AS; Pumphrey RS; Mandal BK; Khoo SH; Wilson PB
    Immunology; 1993 Dec; 80(4):652-3. PubMed ID: 7905861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
    Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
    Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD23 controls IgE synthesis and homeostasis in human B cells.
    Cooper AM; Hobson PS; Jutton MR; Kao MW; Drung B; Schmidt B; Fear DJ; Beavil AJ; McDonnell JM; Sutton BJ; Gould HJ
    J Immunol; 2012 Apr; 188(7):3199-207. PubMed ID: 22393152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma.
    Breen EC; Fatahi S; Epeldegui M; Boscardin WJ; Detels R; Martínez-Maza O
    Tumour Biol; 2006; 27(4):187-94. PubMed ID: 16651853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
    Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
    Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
    Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE.
    Saxon A; Ke Z; Bahati L; Stevens RH
    J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):333-44. PubMed ID: 1698844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aeroallergen-specific IgE changes in individuals with rapid human immunodeficiency virus disease progression.
    Goetz DW; Webb EL; Whisman BA; Freeman TM
    Ann Allergy Asthma Immunol; 1997 Mar; 78(3):301-6. PubMed ID: 9087157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD23 (sCD23) serum levels and lymphocyte subpopulations in peripheral blood in rhinitis and extrinsic and intrinsic asthma.
    Sánchez-Guerrero I; Albaladejo MD; García-Alonso AM; Muro M; Hernández J; Alvarez MR
    Allergy; 1994 Sep; 49(8):587-92. PubMed ID: 7653734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin's lymphomas: evidence from a meta-analysis.
    Huang YS; Zhou X; Yang ZF; Lv ZT
    Ann Hematol; 2018 Aug; 97(8):1317-1325. PubMed ID: 29750316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of CD5+ B cells expressing CD23 in mediating the elevation of serum-soluble CD23 in patients with rheumatoid arthritis.
    Ikizawa K; Yanagihara Y; Kajiwara K; Koshio T; Shida T; Yamada A
    Int Arch Allergy Immunol; 1993; 101(4):416-24. PubMed ID: 7689005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.
    Chomarat P; Briolay J; Banchereau J; Miossec P
    Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.